Schedule 13G ownership disclosure

Taysha Gene Therapies Inc

Common Stock, par value $0.00001 per share · CUSIP: 877619106

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RTW Investments, LP

    Shares: 23,407,133.00 · Class: 8.3%

  • Roderick Wong

    Shares: 23,407,133.00 · Class: 8.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493215-26-000050
Form type
SCHEDULE 13G/A
Filer
RTW INVESTMENTS, LP
CIK
CIK 1493215
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub